Jennison Associates’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-8,333
| Closed | -$5.52M | – | 663 |
|
|
2017
Q1 | $5.52M | Buy |
+8,333
| New | +$5.52M | 0.01% | 501 |
|
|
2016
Q2 | – | Sell |
-18,353
| Closed | -$4.11M | – | 655 |
|
|
2016
Q1 | $4.11M | Buy |
18,353
+118
| +0.6% | +$26.4K | ﹤0.01% | 491 |
|
|
2015
Q4 | $11.1M | Buy |
18,235
+56
| +0.3% | +$34K | 0.01% | 471 |
|
|
2015
Q3 | $9.35M | Buy |
18,179
+11,900
| +190% | +$6.12M | 0.01% | 504 |
|
|
2015
Q2 | $2.75M | Buy |
6,279
+63
| +1% | +$27.6K | ﹤0.01% | 582 |
|
|
2015
Q1 | $2.25M | Buy |
6,216
+19
| +0.3% | +$6.87K | ﹤0.01% | 589 |
|
|
2014
Q4 | $2.22M | Sell |
6,197
-6
| -0.1% | -$2.15K | ﹤0.01% | 564 |
|
|
2014
Q3 | $1.87M | Sell |
6,203
-1,735
| -22% | -$524K | ﹤0.01% | 584 |
|
|
2014
Q2 | $4.86M | Sell |
7,938
-1,906
| -19% | -$1.17M | ﹤0.01% | 497 |
|
|
2014
Q1 | $6.6M | Buy |
+9,844
| New | +$6.6M | 0.01% | 499 |
|